BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 19074082)

  • 1. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Crighton GL; Estcourt LJ; Wood EM; Trivella M; Doree C; Stanworth S
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010981. PubMed ID: 26422767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Estcourt LJ; Stanworth S; Doree C; Trivella M; Hopewell S; Blanco P; Murphy MF
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010984. PubMed ID: 26505729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Estcourt LJ; Stanworth SJ; Doree C; Hopewell S; Trivella M; Murphy MF
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010983. PubMed ID: 26576687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
    Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic platelet transfusions prior to surgery for people with a low platelet count.
    Estcourt LJ; Malouf R; Doree C; Trivella M; Hopewell S; Birchall J
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD012779. PubMed ID: 30221749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.
    Desborough M; Estcourt LJ; Doree C; Trivella M; Hopewell S; Stanworth SJ; Murphy MF
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010982. PubMed ID: 27548292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets Structure, Function and Modulator Capacity in Replacement Therapy.
    Moutinho B; Pinto B; Cardoso R; Botelho MC
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(3):180-184. PubMed ID: 29283062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.
    Apelseth TO; Hervig T; Bruserud O
    Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
    Gubanova MN; Ayupova RF; Zhiburt EB
    Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Slichter SJ; Gernsheimer T; LeBlanc R; Townsend-McCall D; Jones MK; Cuaron L; Bolgiano D
    Transfusion; 2021 Feb; 61(2):393-403. PubMed ID: 33166412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates.
    Stanworth SJ
    Hematology Am Soc Hematol Educ Program; 2012; 2012():512-6. PubMed ID: 23233627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
    Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
    N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic platelet transfusions: should they be a treatment of the past?
    Zeller MP; Al-Habsi KS; Heddle NM
    Curr Opin Hematol; 2014 Nov; 21(6):521-7. PubMed ID: 25203535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet transfusion goals in oncology patients.
    Fasano RM; Josephson CD
    Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An audit of platelet transfusion within the Wellington Cancer Centre.
    Buhrkuhl DC; Karlsson MK; Carter JM
    Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
    Stanworth SJ; Dyer C; Choo L; Bakrania L; Copplestone A; Llewelyn C; Norfolk D; Powter G; Littlewood T; Wood EM; Murphy MF;
    Transfus Med Rev; 2010 Jul; 24(3):163-71. PubMed ID: 20656185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.